Required Reports to a FDA-Accepted Investigational New ...

Adverse Drug Reaction (ADR) options - These options support implementation of Directive 10-92-070. It allows for the evaluation of a suspected ADR by a qualified individual (e.g., clinical pharmacist, clinical pharmacologist) other than the attending physician, as specified in … ................
................